CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 59 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -100.0% | 233 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $18,866,000 | -3.7% | 3,047,800 | 0.0% | 0.04% | -8.3% |
| Q2 2020 | $19,597,000 | +54.9% | 3,047,800 | 0.0% | 0.05% | +29.7% |
| Q1 2020 | $12,648,000 | +0.8% | 3,047,800 | +43.6% | 0.04% | +32.1% |
| Q4 2019 | $12,546,000 | +6.1% | 2,122,800 | -3.0% | 0.03% | -3.4% |
| Q3 2019 | $11,823,000 | -33.1% | 2,189,400 | 0.0% | 0.03% | -32.6% |
| Q2 2019 | $17,668,000 | +1.9% | 2,189,400 | 0.0% | 0.04% | 0.0% |
| Q1 2019 | $17,340,000 | +280.3% | 2,189,400 | +109.8% | 0.04% | +258.3% |
| Q4 2018 | $4,560,000 | – | 1,043,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |